These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27693800)

  • 1. Effects of ZD0947, a novel and potent ATP-sensitive K
    Mori K; Yamashita Y; Teramoto N
    Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZD0947, a sulphonylurea receptor modulator, detects functional sulphonylurea receptor subunits in murine vascular smooth muscle ATP-sensitive K
    Yamamoto T; Takahara K; Uchida K; Teramoto N
    Eur J Pharmacol; 2017 Apr; 800():34-39. PubMed ID: 28213290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes.
    Aishima M; Tomoda T; Yunoki T; Nakano T; Seki N; Yonemitsu Y; Sueishi K; Naito S; Ito Y; Teramoto N
    Br J Pharmacol; 2006 Nov; 149(5):542-50. PubMed ID: 17016513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myorelaxant action of fluorine-containing pinacidil analog, flocalin, in bladder smooth muscle is mediated by inhibition of L-type calcium channels rather than activation of KATP channels.
    Philyppov IB; Golub AА; Boldyriev OI; Shtefan NL; Totska K; Voitychuk OI; Shuba YM
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):585-92. PubMed ID: 26976335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
    Li CG; Cui WY; Wang H
    Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
    Shindo T; Katayama Y; Horio Y; Kurachi Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of ATP-sensitive K(+) channel subunits expressed in mouse portal vein.
    Yamamoto T; Takahara K; Inai T; Node K; Teramoto N
    Vascul Pharmacol; 2015 Dec; 75():29-39. PubMed ID: 26163942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
    Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
    Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
    Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
    Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome K
    Gao J; McClenaghan C; Matreyek KA; Grange DK; Nichols CG
    J Pharmacol Exp Ther; 2023 Sep; 386(3):298-309. PubMed ID: 37527933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
    Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
    J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes.
    Mele A; Camerino GM; Calzolaro S; Cannone M; Conte D; Tricarico D
    Biochem Pharmacol; 2014 Sep; 91(2):266-75. PubMed ID: 24998494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
    Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.